A Scalable Solution for High-Quality Plasmid DNA
App Note / Case Study
Published: January 22, 2025

Credit: iStock
Plasmid DNA (pDNA) is a key material for producing gene therapies, mRNA and DNA vaccines. The alkaline lysis process to isolate pDNA is simple on the benchtop, but it’s challenging at industrial scale.
This application note demonstrates a controlled, scaled-up process using single-use equipment―including static inline mixers―and consumables for an E. coli cell line with 6.3 kbp model plasmid.
Download this application note to:
- Discover the high step yields and quick timing for the developed process
- Explore the scalability with data from both 50 L and 200 L fermentors
- See a diagram of the single-use setups
Alkaline lysis for
pDNA using a static
inline mixer
cytiva.com
Controlled alkaline lysis of E. coli cells using singleuse static inline mixer to release plasmid DNA (pDNA)
for further purification and use in biopharmaceutical
manufacturing
Plasmid DNA (pDNA) is a prerequisite in the growing biopharmaceutical field of mRNA and
in gene therapy manufacturing. Plasmids used in BioProcess™ applications are commonly
in the range of 5 to 20 kilobase pairs (kbp). Here we present a controlled scaled-up process
using single-use equipment and consumables for an E. coli cell line with 6.3 kbp model plasmid.
Individual lysis process parameters can be adjusted for optimization with the goal of
maintaining pDNA quality and yield. We also show how the lysis and clarification process fit
into the pDNA workflow and can be used in scaled-up pDNA processes from 50 to 200 L.
Previously published material around pDNA production purification and analysis from Cytiva
is available in the following application notes:
1. A scalable single-use two-step pDNA purification process
2. Three-step supercoiled plasmid DNA purification
Introduction
pDNA is an important genetic engineering tool used to clone and amplify or express genes
for biotechnology applications. pDNA of good manufacturing practice (GMP) grade has many
applications including DNA vaccines and gene therapy, with the production of viral vectors
and mRNA being dependent on the production of pDNA (1).
With the increasing use of plasmid vectors in different therapeutic areas, the focus on
manufacturability, as well as regulatory requirements for these processes, have increased.
Manufacturers of pDNA must comply with GMP principles even when plasmids are not
themselves therapeutic (Fig 1 below).
Fig 1. Overview of where GMP principles apply for pDNA manufacturing. Adapted from reference 2.
Starting material – active substance – finished product
In vivo gene
therapy: mRNA
In vivo gene therapy:
nonviral vector
In vivo gene
therapy: viral vector
Ex vivo genetically
modified cells
Plasmid
manufacturing
Plasmid
manufacturing
Plasmid
manufacturing
Donation
procurement
In vitro
transcription
Bacterial bank
established
Cell bank
established
Cell bank
established
mRNA manufacturing
and purification
DNA manufacturing
and purification
Vector manufacturing
and purification
Genetically modified
cells manufacturing
Formulation, filling
Formulation, filling
Formulation, filling
Formulation, filling
Plasmid
manufacturing
GMP principles should be applied
GMP principles applied
Vector
manufacturing
2 CY45846-15Jan25-AN
Plasmids are amplified through a microbial system in a fermentation process followed
by a series of purification steps to reach the purity and quality goals. A critical step in the
purification process is alkaline lysis, where concentrated cells are suspended at neutral pH
and lysed by adding an alkaline solution containing detergent. The lysate is then neutralized,
resulting in the immediate formation of a white precipitate or flocculate consisting mainly of
cell debris, denatured proteins, and genomic DNA.
The lysis is often performed in batch mode and removal of the flocculate/precipitate is often a
centrifugation operation at lab scale. However, the batch mode of the lysis process is difficult
to close and scale when fermentation volumes increase.
An additional challenge when performing lysis in batch mode is achieving optimized mixing
while minimizing shear during the brief lysis period, which typically lasts only a few minutes
at alkaline pH. Prolonged lysis time risks the degradation and denaturation of supercoiled
plasmids (SC), while high shear forces risk fragmenting genomic DNA. Both issues can
complicate the purification process and reduce yield and quality.
While batch lysis using mixers is available and performed at small scale, control of the lysis
process while maintaining appropriate mixing and lysis time parameters can be challenging as
cell mass and volumes increase.
Our main objective of this work is to incorporate a controlled and scalable process for E. coli
lysis with single-use equipment and consumables. The pDNA workflow typically includes the
lysis step between the cell concentration and clarification depth filtration process steps in the
midstream process (Fig 2).
Fig 2. An overview of pDNA production through the midstream process. Lysis was performed directly from diluted
cell suspension feed using the single-use static inline mixer.
Cell concentration
Continuous centrifugation with cell wash
Upstream production
E. coli DH10B strain
Lysis
Alkaline cell lysis with static inline mixer
and lysis neutralization
Precipitation and flocculation lift
Calcium chloride precipitation and
ammonium bicarbonate flocculation lift
Clarification
Depth filtration with PDP8 depth-filter sheets
The alkaline lysis process with the static inline mixer allows for optimized mixing and reduced
shear to avoid fragmentation of genomic DNA and denaturation and degradation of SC
plasmid. The single-use components allow easy setup, reduce the need for post-use cleaning,
and ensure a closed system for the cell concentration and lysis process.
CY45846-15Jan25-AN 3
This application note shows the performance of a static inline mixer for alkaline cell lysis and
pDNA release from cell suspension feed material. We performed the work at the 50 and 200
L fermenter scale using a single-use centrifuge for cell concentration, followed by a full pDNA
midstream process including alkaline lysis operation, calcium chloride precipitation of RNA,
clarification through flocculate lift (2), and depth filtration.
Materials and methods are described in detail at the end of the document.
Results and discussion
We produced the pDNA plasmid starting material for two runs in Xcellerex™ XDR-50 MO and
XDR-200 dual-purpose (DP) fermenters. E. coli cells were concentrated, washed, and buffer
exchanged using a continuous single-use centrifuge where the plasmid-containing cells
were retained (heavy phase). The fermenter medium (light phase) was set to waste.
The cells in the heavy phase were retained in a circulation tank, recirculated in the centrifuge,
and washed with cell suspension buffer (50 mM Tris, 50 mM glucose, 10 mM EDTA, pH 7.5),
while keeping the volume constant, equivalent of > two buffer exchanges.
We determined the wet cell weight (WCW) of the E. coli cells and diluted to a final
concentration of 15 L/kg of cell suspension buffer to WCW. For the 50 and 200 L fermenter
runs, the recirculation vessel and dilution vessels were single-use Allegro™ 50 L and
Xcellerex XDUO-200 single-use mixers, respectively. The starting weights of the lysis
material were 50.7 and 100.0 kg with processed wet cell weights of 3.44 and 6.66 kg for the
two experiments (for the 200 L run only 50% of the WCW from the cell concentration step
was further processed through the lysis).
The lysis process employed single-use components throughout, including the static inline
mixer assembly, mixer bags, and ReadyToProcess™ tubing assemblies. The ½” static inline
mixer is a 19 cm long, 12.7 mm o.d., helical mixer. The single-use components, peristaltic
pumps, and pressure monitor were organized on a ReadyKart™ mobile processing station.
The cell suspension feed material was mixed at 30 rpm in the Allegro 50 L mixer through the
process until reaching the minimum 2 L agitation volume to keep it heterogeneous through
the lysis process. The static inline mixer flow rate was controlled at a total flow rate of 500
mL/min through the mixer (per element if multiple elements are used Fig 3B). Half of the flow
came from the cell suspension and half from the lysis buffer (0.2 M NaOH, 1% SDS) giving 1:1
proportion of the two solutions.
The 500 mL/min flow rate corresponds to a flow velocity of 0.067 m/s. The target was 1 min of
lysis time and the length of the 1/2” i.d. tubing, post static inline mixer was scaled to match
this time (4 m for the 50 L run and 7.8 m for the 200 L run). Tubing was coiled in ~ 0.3 m (1 ft)
diameter loops before the introduction of the neutralization buffer (3 M potassium acetate,
2.07 M acetic acid at 2°C to 8°C) at a Y junction followed by collection into single-use mixers
(XDUO 200 L mixer for the 50 L run and XDUO 500 L mixer for the 200 L run).
Figure 3 shows the setups of the runs.
The inlet pressure of the static inline mixer was consistent through the entire runs at 0.25 to
0.35 bar (Fig 4) and showed no sign of clogging during the runs. Processing time for each of
the runs was ~ 3 h.
The final neutralized lysate weighed 147.7 and 311.1 kg, collected into XDUO-200 or XDUO-500
mixers for the 50 and 200 L runs, respectively. The lysis process yielded > 90% of pDNA released
from the lysis process based on pDNA titers in the neutralized lysate product as compared to
titer from fermenter samples processed with pDNA miniprep kits (Table 1).
Product quality data (Table 2) post-lysis shows that the static inline mixer lysis did not affect the
pDNA supercoiled/open circular (SC/OC) ratio and product impurities between runs.
4 CY45846-15Jan25-AN
(A)
Cellsuspension
product
Lysis
buffer
Neutralization
buffer
Post-lysis
neutralized
product
Pump 2
Pump 1
Pump 3
Cell-suspension
surge-tank pump
Lysis-tubing
loop
½” inline
mixers
pH
2.0
P2
pH
1.0 P1
(B)
Cellsuspension
product
(low-volume
surge tank)
Cellsuspension
product
Lysis
buffer
Neutralization
buffer
Post-lysis
neutralized
product
Pump 2
Pump 1
Pump
setups
Pump 3
pH
sensors
(optional)
½” static
inline mixers
Pressure
sensors
pH sensors
(optional)
P3
pH
1.0 P1
pH
2.0 P2
(C)
Calcium
chloride
precipitation
buffer
Ammonuim
bicarbonate
flocculation
buffer
Post-lysis
neutralized
product
Pump
To depth-filtration
process step
Air vent
Fig 3. Setup for the pDNA lysis process for the 50 L fermenter scale (A) and 200 L fermenter scale (B) using
two static inline mixer elements to optimize process time. (C) Post-lysis operations with calcium chloride and
ammonium bicarbonate.
CY45846-15Jan25-AN 5
Fig 4. Pressure before static inline mixer(s) during lysis runs.
Table 1. End of fermentation through lysis process data. End of fermentation concentration performed via pDNA miniprep kits and spectrophotometry.
Continuous centrifugation process step yield was calculated based on the percentage of cell mass at the end of fermentation compared to the continuous
centrifugation amount1
Table 2. Fermenter and lysis analytical data1
0.40
0.35
0.30
0.25
0.20
0.15
0.10
0.05
0.00
0 50 100 150 200 250 300 350
Neutralized lysis weight (kg)
50 L pDNA run
Pressure before static inline mixer (bar)
200 L pDNA run, mixer nr. 1 200 L pDNA run mixer nr. 2
Process sample Fraction weight (kg) pDNA conc. (mg/mL) pDNA amount (g) Step yield (%) Overall process yield (%)
Xcellerex XDR fermenter XDR-50 XDR-200 XDR-50 XDR-200 XDR-50 XDR-200 XDR-50 XDR-200 XDR-50 XDR-200
End of fermentation1 37.0 200.0 0.17 0.07 6.29 14.2 NA NA NA NA
Continuous centrifugation2 36.18 41.68 NA NA 5.47 10.3 87% 73% 87% 73%
Neutralized lysate3 147.7 311.1 0.034 0.018 5.02 5.60 92% 109% 80% 79%
1 End of fermentation sample pDNA concentration analysis was performed using a NanoDrop microvolume spectrophotometer on batch lysis material purified using DNA
miniprep kit (see Materials and methods for additional information).
2 Continuous centrifugation pDNA amount data was extrapolated based on process step yield and WCW retained during continuous centrifugation.
3 The 200 L run only forward processed 50% of the material from the cell concentration through the lysis process step. The step yield and overall process yield data were
calculated accordingly. The neutralized lysate sample pDNA concentration analysis was performed via the Sepharose™ HP chromatography resin method (3) (see Materials and
methods for additional information). The 200 L Xcellerex™ XDR fermenter run had a paired yield excursion with continuous centrifugation and neutralized lysate step yields. The
overall process yields at the neutralized lysate stage were comparable between the 50 and 200 L runs.
Process sample
E. coli DNA (µg gDNA/
mg pDNA)
E. coli HCP (µg HCP/
mg pDNA)
Endotoxin (E.U./mg
pDNA) SC pDNA (%)
Xcellerex XDR fermenter XDR-50 XDR-200 XDR-50 XDR-200 XDR-50 XDR-200 XDR-50 XDR-200
End of fermentation1 N/A N/A N/A N/A N/A N/A 66.6% 55.8%
Neutralized lysate 126 829 812 490 70 340 32 350 50% 60%
1 See Materials and methods section for additional details on analytical methods.
6 CY45846-15Jan25-AN
We recommended that you perform lysis optimization for specific E. coli cell lines and
plasmids to improve product quality and yield. Some key parameters for the lysis process to
optimize are:
• Cell suspension dilution
• Lysis and neutralization buffer composition and detergent concentration
• Lysis time/flow rate
Post-lysis, a calcium chloride precipitation, and flocculation lift with ammonium bicarbonate
was performed within the Xcellerex XDUO mixers. We added 5 M of calcium chloride buffer
to precipitate and reduce RNA. We also added 120 g/L of ammonium bicarbonate buffer to
bring the precipitated material (precipitated RNA and cell debris) to the top of the mixer bag
and separate it from the lysis suspension with the target pDNA. This allows the lysis material
to be depth-filtered without loading the precipitated material onto the depth filters, which
increases the filtration load capacity. Additions of both buffers occurred through the bottom
port for addition close the mixer (Fig 3C).
We performed depth filtration with Stax™ disposable depth filter capsules and PDP8 filter
membranes from the bottom outlet of the Xcellerex XDUO mixer. Filtration was stopped
when the filtration of precipitated material started. Cake filtration with the K900P depth
filter and filter aids (Celpure C300 and Harborlite 900S) was tested on the precipitated lysis
material at small scale with similar results (data not shown) to flocculate lift material shown
in this study for additional clarification options.
Step yields and individual analytics for the precipitation through depth filtration process
steps were not quantitated until after tangential flow filtration (TFF) 1 buffer exchange due
to chemical incompatibilities with assays.
Conclusions
• Single-use, static inline mixer for E. coli lysis and pDNA release provides a controlled
and scalable lysis process with step yields around 90%.
• Processing of a 50 L fermenter batch with one static inline, single-use mixer in ~ 3 h.
• Process steps can be closed operations without the need for cleaning in place (CIP)
of equipment.
• Ability to optimize lysis parameters for product quality and process yield targets.
• Multiple single-use mixer sizes available for use (½” and ¼” i.d. static inline mixers)
in tubing sets.
• Scalable clarification process (precipitation or flocculation lift and depth filtration) for
efficient removal of cell debris and precipitated material after lysis.
Scalable viral vector processes
Get tips to improve your viral vector process in this article (5 min read)
Learn more
CY45846-15Jan25-AN 7
References
1. EMA/246400/2021, Questions and answers on the principles of GMP for the manufacturing
of starting materials of biological origin used to transfer genetic material for the
manufacturing of ATMPs. https://www.ema.europa.eu/en/documents/other/questionsanswers-principles-gmp-manufacturing-starting-materials-biological-origin-usedtransfer_en.pdf
2. Blom H, Bennemo M, Berg M, Lemmens R. Flocculate removal after alkaline lysis in plasmid
DNA production. Vaccine. 2010 Dec 10;29(1):6-10. doi: 10.1016/j.vaccine.2010.10.021.
3. Bennemo M, Blom H, Emilsson A, Lemmens R. A chromatographic method for determination
of supercoiled plasmid DNA concentration in complex solutions. J Chromatogr B Analyt
Technol Biomed Life Sci. 2009 Aug 15;877(24):2530-6. doi: 10.1016/j.jchromb.2009.06.037.
Materials and methods
Two experiments were performed, fermentation in a 50 L fermenter and a scaled-up process
to a 200 L fermenter. Both experiments will be described in the sections below.
pDNA production
E. coli DH10B strain with integrated target 6.3 kbp plasmid were grown in Terrific Broth (TB)
with a glucose-based feed using the Xcellerex XDR-50 MO and XDR-200 DP fermenters.
Fermentation was performed at 37°C for 16 to 17 h. Fermentation data and equipment are
captured in Table 4.
Table 3. Fermentation procedure for 50 and 200 L fermenter scales
Step Procedure Details 50 L XDR run 200 L XDR run
1 Fermentation Fermentation process duration (h): 16 17
Final fermenter weight (kg): 37.0 200.0
Final fermenter OD600: 52.0 42.5
Final fermenter, solids (%): 10.7 9.2
Fermenter total cell mass (kg): 4.0 18.4
Fermenter equipment: Xcellerex XDR-50 MO Xcellerex XDR 200
Dual Purpose
Cell concentration
We chilled fermenter product to 20°C in the fermenter before starting cell concentration.
Centrifugation was performed with an Alfa Laval CultureOne Primo or CultureOne Maxi
single-use centrifuge with Allegro 50 L mixer or Xcellerex XDUO-200 mixer as recirculation
vessel, for 50 and 200 L runs, respectively. The centrifuge heavy phase was retained and
recirculated back to the recirculation vessel. We maintained a constant weight of the
recirculation vessel by adding the cell wash buffer to the top of the vessel for buffer exchange.
The recirculation vessel was buffer exchanged three times for the 50 L run. We buffer exchanged
the 200 L run two times, then we collected the heavy phase during the final pass into a 50 L
Allegro mixer. The high percentage of solids of the heavy-phase collection during the 200 L
run at 32.0% may have a higher degree of assay variability due to the higher percentage of
solids. At the end of centrifugation, we flushed the centrifuge with cell wash buffer via the
centrifuge feed line. The centrifuge light phase was collected as waste and stayed below 30
nephelometric turbidity units (NTU) throughout both runs (data not shown). We measured
turbidity using a LaMotte 2020we turbidimeter with offline samples taken from the light
phase line. Cell concentration data, buffers, and equipment are described in Table 4.
8 CY45846-15Jan25-AN
Table 4. Cell concentration procedure for 50 and 200 L fermenter scales
Step Procedure Details 50 L XDR-MO run 200 L XDR-200 DP run
2 Cell concentration Centrifugation process
duration (h)
1.9 2.6
Buffer exchanges Three times Two times
(three times during cell
suspension dilution)
Post centrifugation weight (kg) 32.20 41.68
Post-centrifugation solids (%) 9.5 32.0*
Post-centrifugation total cell
mass (kg)
3.44 13.3
Cell wash buffer 50 mM Tris, 10 mM EDTA, 50 mM glucose, pH 7.5
Single-use centrifuge
equipment
Alfa Laval CultureOne Primo Alfa Laval CultureOne Maxi
Recirculation vessel Allegro 50 L mixer Xcellerex XDUO 200 mixer
Cell-wash buffer transfer pump Watson Marlow 520 series
peristaltic pump
Watson Marlow 520 series
peristaltic pump
* The heavy phase collection during the 200 L run at 32.0% and low yield of step may be caused by the high wet cell weight test
variability at higher percentage of solids.
Lysis with static inline, single-use mixer
We diluted the post-centrifugation cell suspension material with the cell suspension
buffer (50 mM Tris-HCl, 10 mM EDTA, 50 mM glucose, pH 7.5) to a target of 15 L/kg of cell
suspension buffer to total cell mass in the Allegro 50 L mixer or Xcellerex™ XDUO-200 mixer.
The 50 L run was set up using ReadyToProcess™ single tubing assemblies with ReadyMate™
connections with the inline static mixer. The cell suspension was continually mixed until the
minimum agitation volume of 2 L was reached on the Allegro 50 L mixer.
The 200 L run utilized two static inline mixers run in parallel, which were set up at identical
heights and lengths of inlet and outlet tubing from static mixers. We tested flow rates
through the static mixers and within 5% of flow rate through each mixer before combining
flows through the ½” i.d. lysis tubing. The 200 L run used both an initial cell suspension mixer
(Xcellerex XDUO-200) and a surge vessel (Allegro 50 L mixer) to maintain mixing through the
process step.
We initially filled the Allegro 50 L mixer to 20 kg with cell suspension feed and when the
minimum mixing volume of the Xcellerex XDUO-200 mixer was reached (44 L), the remaining
cell suspension was pumped into the surge tank to continue mixing to the minimum
agitation volume of 2 L.
Peristaltic pumps for the cell suspension, lysis buffer, and neutralization buffer were standardized
at the set flow rate before runs. We primed all lines up to static inline mixer or Y junctions
before starting the lysis process step. The cell suspension and lysis buffer pumps were started
at the same time and the neutralization buffer pump was started when the lysis product
reached the Y junction. The cell suspension feed material was mixed at ~ 30 to 50 rpm in the
Allegro 50 L mixer and Xcellerex XDUO-200 mixer until the minimum agitation volume of
each was reached to keep the cell suspension heterogeneous through the lysis process.
The neutralization buffer was chilled between 2°C and 8°C before use. For the 200 L run, we
processed only 50% of the centrifuged cell concentration material through the lysis step.
The static inline mixer lysis data, buffers, and equipment are described in Table 5.
CY45846-15Jan25-AN 9
Table 5. Lysis procedure for 50 and 200 L fermenter scales
Step Procedure Details 50 L XDR run 200 L XDR run1
3 Lysis with static
inline mixer
Lysis process duration (h) 3.2 3.2
Total cell mass processed (kg) 3.44 6.66
(50% forward
processed)
Cell suspension dilution
(L of buffer/kg of cell mass)
15 ~ 15
Weight of cell suspension feed (kg): 50.7 100.0
Number of static inline mixers used 1 2 (in parallel)
Cell suspension, lysis buffer, and
neutralization buffer pump flow rates (L/min)
0.250 0.500
Individual static inline mixer flow rate (L/min) 0.500 ~ 0.500
Individual static inline mixer velocity (m/s) 0.066 0.066
Lysis time post-static inline mixer 1 min
(4 m of ½” i.d. tubing)
1 min
(7.8 m of ½” i.d. tubing)
Cell suspension buffer 50 mM Tris, 10 mM EDTA, 50 mM glucose, pH 7.5
Lysis buffer 0.2 M NaOH, 1% SDS
Neutralization buffer 3 M potassium acetate,
2.07 M acetic acid
Cell suspension, lysis buffer, and
neutralization buffer pumps
Watson Marlow 520
series peristaltic pump
Watson Marlow 520
series peristaltic pump
Cell suspension surge tank transfer pump N/A Watson Marlow 620
series peristaltic pump
Neutralized lysis collection vessel: Xcellerex XDUO 200
mixer
Xcellerex XDUO 500
mixer
Final neutralized lysate weight (kg): 147.7 311.1
Neutralized lysate precipitation, flocculation lift, and clarification depth filtration
The neutralized lysate material was mixed in the Xcellerex XDUO mixer for 2 to 5 min before
further processing. Setup of the XDUO mixer bag was completed by attaching single-use
tubing sets to the bottom tubing port for precipitation and flocculation lift additions then
depth filtration and an air filter were attached to the top port of the bag.
We added 5 M of calcium chloride (CaCl2
) through the XDUO mixer bag bottom port while
mixing at a slow speed to a final concentration of 1 M CalCl2
. Mixing was continued for an
additional 2 to 5 min post-addition then stopped and held for ≥ 1 h to allow precipitate to form.
We added 120 g/L of ammonium bicarbonate flocculation lift buffer through the XDUO mixer
bag bottom port while mixing to a final concentration of 8 g/L ammonium bicarbonate. Offgassing during the flocculation lift addition brings the precipitated material to the top of the
bag and is held there with excess gas exiting through the air filter on a top port. Flocculated
material was held overnight without issue before starting the clarification depth filtration of
flocculated lysate material.
We performed clarification depth filtration with Stax™ capsule, HP-Series, and PDP8 filter sheets.
We used Stax PDP8 depth filters of 1 and 2 m2
at a filter loading of 165 L/m2
and 187 L/m2
, for
the 50 L and 200 L runs, respectively. Watson Marlow 620 peristaltic pump with associated
tubing sets and SciLog pressure sensors were used. The filters were flushed with WFI for ≥
100 L/m2
and flush buffer (50 mM Tris, 50 mM glucose, 10 mM EDTA, pH 7.5) for ≥ 10 L/m2
at
150 LMH before use. Flocculated material was filtered through depth filters at 100 LMH.
Filtration of the product was stopped and switched to the buffer flush when the flocculated
material reached the bottom outlet of the bag. We performed a post-product filtration flush
at ≥ 10 L/m2 at 100 to 150 LMH to maximize product recovery. The max. pressure observed
during filtration was 0.35 and 0.25 bar (for the 50 and 200 L runs respectively. The clarified
product was collected into a 200 or 500 L XDUO mixer. For the 200 L run, only 50% of the
centrifuged cell concentration material was processed through the lysis and clarification
process steps.
10 CY45846-15Jan25-AN
Table 6. Precipitation, flocculation lift, and depth filtration procedure for 50 and 200 L fermenter scale
Step Procedure Details 50 L XDR run 200 L XDR run
4 Precipitation,
flocculation
lift, and depth
filtration
Precipitation buffer 5 M calcium chloride
Flocculation lift buffer 120 g/L ammonium
bicarbonate
Calcium chloride and flocculation lift buffer
addition pump
Watson Marlow 620
series peristaltic
pump
Watson Marlow 620
series peristaltic
pump
Flocculate Lift material weight (kg) 213.0 449.2
Depth filtration flush buffer 50 mM Tris,
10 mM EDTA,
50 mM glucose,
pH 7.5
Depth filtration filters: 1 × 1 m2 2 × 1 m2
Depth filtration product filtration flowrate (L/min) 1.7 3.5
Depth filtration product filtration weight (kg) 177.7 409.2
Depth filtration pump Watson Marlow 620
series peristaltic
pump
Watson Marlow 620
series peristaltic
pump
Depth filtration collection vessel Xcellerex XDUO 200
mixer
Xcellerex XDUO 500
mixer
Depth-filtered product weight (kg) 196.6 437.2
Analytical methods
pDNA titers were determined for the end of fermentation samples by a DNA miniprep
(Qiagen QIAprep Spin miniprep kit) followed by UV-Vis quantitation with a NanoDrop
spectrophotometer (Thermo Fisher). Following this application note, we determined
neutralized lysate titers using a Sepharose™ High Performance chromatography resin
method (PlasmidSelect Xtra screening kit, Cytiva).
We verified the correct plasmid by agarose gel electrophoresis (AGE) +/- pDNA restriction
cleavage. Following vendor-recommended protocols, we used the method at the end of
fermentation miniprep samples (precast agarose E-gel 1%, Invitrogen and New England
Biolabs enzymes).
We determined pDNA SC/OC ratio by AGE and the Invitrogen gels following the vendorrecommended protocol. Imaging was performed with an Amersham™ ImageQuant™ 800
biomolecular imager.
To analyze eluate purity: E. coli residual DNA was determined using qPCR (resDNASEQ
quantitative E. coli DNA kits, Thermo Fisher), following the vendor-recommended protocol.
E. coli host cell protein (HCP) was determined via ELISA assay (E. coli HCP ELISA kit, 2G,
Cygnus), following the vendor-recommended protocol.
Endotoxin amount was determined via an LAL test, using the Endosafe nexgen-PTS system
(Charles River, LAL test cartridges [FDA-licensed], 1.0 to 0.01 EU/mL), following the vendorrecommended protocol.
pDNA SC/OC ratio was determined by capillary electrophoresis (dsDNA 1000 kit, Sciex),
following the vendor-recommended protocol
Precipitation, flocculation lift, and depth filtration data, buffers, and equipment are shown
in Table 6.
CY45846-15Jan25-AN 11
cytiva.com
Cytiva and the Drop logo are trademarks of Life Sciences IP Holdings Corporation or an affiliate
doing business as Cytiva. Amersham, Allegro, BioProcess, ImageQuant, ReadyKart, ReadyMate,
ReadyToProcess, Sepharose, Stax, and Xcellerex are trademarks of Global Life Sciences Solutions
USA LLC or an affiliate doing business as Cytiva. Any other third-party trademarks are the
property of their respective owners.
© 2025 Cytiva
CY45846-15Jan25-AN
Brought to you by

Download the Application Note for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version